Mr. Etienne Grima reports

CARDIOCOMM SOLUTIONS AND PREDICTIV AI ENTER INTO STRATEGIC AI COLLABORATION

Cardiocomm Solutions Inc. has entered into a strategic collaboration, joint development and intellectual property agreement with Predictiv AI Inc. of North York, Ont.

The agreement establishes a framework under which the companies may identify, assess and, where mutually approved, pursue specific projects involving health care software, medical software, artificial intelligence, automated analytics, remote patient monitoring, clinical decision support, biosignal interpretation, predictive analytics, workflow optimization and software as a medical device applications.

Under the collaboration framework, Predictiv AI is expected to contribute capabilities in artificial intelligence, telemetry aggregation, data intelligence and predictive analytics, while Cardiocomm is expected to contribute its proprietary medical software, ECG management technologies, regulatory experience, quality system expertise and commercialization experience applicable to medical devices and medical software.

The agreement is structured to preserve each company's existing intellectual property, prior art, confidential information and proprietary technologies, while setting out procedures for the ownership, protection and use of any intellectual property that may be jointly developed under approved projects. Specific projects, deliverables, budgets, timelines, regulatory activities and commercialization commitments will require separately approved written project schedules or definitive agreements.

For any project that may involve regulated medical software, software-as-a-medical-device, clinical workflows or medical device-related deliverables, Cardiocomm will retain final decision-making authority over quality, regulatory, validation, cybersecurity, information security and release-related matters, including compliance with Cardiocomm's ISO 13485 quality management system and ISO 27001 information security requirements.

The areas of potential collaboration include AI-enabled remote patient monitoring, automated ECG and biosignal interpretation, multiparameter data fusion, clinical workflow automation, event prioritization, triage support, predictive analytics and regulated software applications. The parties also expect to evaluate opportunities intended to support healthcare providers in reviewing medical data more efficiently and identifying clinically relevant events.

In connection with the collaboration agreement, the company notes that its chief executive officer, Etienne Grima, also serves as a director of Predictiv AI. Mr. Grima disclosed his interest in the matter and did not participate in the board's consideration or approval of the agreement. Any future project-specific commercial terms are expected to be addressed separately through written project schedules or definitive agreements, as applicable.

About Cardiocomm Solutions Inc.

Cardiocomm Solutions is a health care technology company focused on the development of medical software, remote patient monitoring solutions, and data management platforms for the collection, analysis, and reporting of cardiac and related physiological data. The company's technologies support patients, physicians and health care organizations through clinically relevant, connected digital health solutions. Cardiocomm Solutions has earned the ISO 13485 and ISO 27001 certifications, is HIPAA compliant, and holds medical device clearances and sales licences from the United States (Food and Drug Administration) and Canada (Health Canada).

About Predictiv AI Inc.

Predictiv AI is a Canadian artificial intelligence company focused on developing vertical AI applications for defined industries. The company's products address fleet operations and communications, including fleet management software, AI-based agents for voice, chat and SMS, and tools designed to support structured operational workflows.

We seek Safe Harbor.